Results 221 to 230 of about 43,902 (289)

Perils and Promises of Therapeutic Approaches for the Stem Cell Disease Fibrous Dysplasia [PDF]

, 2019
Saggio, Isabella
core   +1 more source

Perioperative Denosumab Versus Bisphosphonates for MIDLF Surgery in Patients With Osteopenia: A Short-Term Prospective Cohort Study. [PDF]

Global Spine J
Changsheng H, Yue L, Wang S, Sun H.
europepmc   +1 more source

A Case of Acute-phase Reaction of Denosumab which was Difficult to Exclude Aggravation of Original Cancer Pain

, 2016
Gakuji Osawa, Etsuko Aruga, Meiko Mayuzumi, Keiko Kubo, Miyuki Nukita, Azumi Hidaka, Katsumasa Misawa   +6 more
openalex   +2 more sources

Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis

, 2020
Kosuke Ebina, Jun Hashi­moto, Masafumi Kashii, Makoto Hirao, Akira Miyama, Hiroyuki Nakaya, Shigeyoshi Tsuji, Koichiro Takahi, Hideki Tsuboi, Gensuke Okamura, Yuki Etani, Kenji Takami, Hideki Yoshikawa   +12 more
openalex   +1 more source

Mechanisms of Chemotherapy-Induced Diarrhoea [PDF]

, 2017
Davies, A, French, S, Pirmohamed, M
core   +1 more source

Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases? [PDF]

J Clin Med
Mısırcı S, Ekin A, Yağız B, Coşkun BN, Büyükuysal MÇ, Dalkılıç E, Pehlivan Y.   +6 more
europepmc   +1 more source

Population PK Modeling of Denosumab Biosimilar MB09 and Reference Denosumab to Establish PK Similarity. [PDF]

Pharmaceutics
Sánchez-Vidaurre S, Paravisini A, Queiruga-Parada J.   +2 more
europepmc   +1 more source

Monoclonal Antibodies and Osteonecrosis of the Jaw: A Systematic Review of Risk, Incidence, and Clinical Management in Dentistry. [PDF]

Int J Dent
Dipalma G, Inchingolo AD, Guglielmo M, Palumbo I, Riccaldo L, Morolla R, Inchingolo F, Venere DD, Palermo A, Inchingolo AM.   +9 more
europepmc   +1 more source

Severe Symptomatic Hypocalcemia after Denosumab Administration in an End-Stage Renal Disease Patient on Peritoneal Dialysis with Controlled Secondary Hyperparathyroidism [PDF]

, 2019
Agarwal, Mohit, Csongrádi, Éva, Echols, Vonda, Fülöp, Tibor, Juncos, Luis A., Koch, Christian A., Tapolyai, Mihály   +6 more
core  

Urinary calcium and bone resorption markers during 3 years of denosumab treatment in pediatric osteogenesis imperfecta. [PDF]

JBMR Plus
Stasek S, Reincke S, Rehberg M, Semler O, Hoyer-Kuhn H.   +4 more
europepmc   +1 more source